Peripheral hematological inflammatory signatures in the amyloid-defined Alzheimer’s disease continuum: associations with disease stage, cognitive function, and astroglial activation
- 1Department of Neurology, West China Hospital, Sichuan University
- 2Department of Cancer Center, Army Medical Center of PLA (Daping Hospital), Army Medical University
Abstract
Background: Peripheral immune-inflammatory dysregulation has been implicated in Alzheimer’s disease (AD) and cognitive decline. However, whether routinely available hematological inflammatory indices are associated with biological and clinical stages across the AD continuum and provide incremental information beyond established risk factors remains unclear. We aimed to investigate the associations of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and hemoglobin-to-red blood cell distribution width ratio (HRR) with AD continuum stage, cognition, and AD biomarkers.
Methods: This cross-sectional study included 267 participants who underwent comprehensive cognitive assessment, peripheral blood testing, and amyloid-β positron emission tomography (Aβ-PET) imaging. Participants were categorized into three groups according to cognitive status and available amyloid biomarker profiles: cognitively unimpaired (CU-Aβ ⁻ ), amyloid-positive mild cognitive impairment (MCI-Aβ ⁺ ), and amyloid-positive Alzheimer’s disease dementia (AD-Aβ ⁺ ). Hematological inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and hemoglobin-to-red cell distribution width ratio (HRR), were calculated from routine blood parameters. A composite inflammatory index (Inflam_PC1) was derived using principal component analysis. Ordinal logistic regression models were used to examine the associations between inflammatory indices and AD continuum stage after adjustment for demographic, vascular, metabolic, and genetic factors.
Results: Inflammatory profiles differed across the AD continuum, with increased NLR and SII and decreased HRR levels in more advanced stages. Higher NLR (OR = 1.54, 95% CI: 1.25-1.91, P < 0.001) and SII (OR = 1.29 per 100-unit increase, 95% CI: 1.15-1.45, P < 0.001) were independently associated with advanced AD continuum stages, whereas HRR was not. The composite inflammatory signature showed the strongest association (OR = 1.63 per SD increase, 95% CI: 1.30-2.03, P < 0.001) and provided incremental statistical improvement beyond conventional risk factors. Higher inflammatory burden was associated with poorer cognitive and functional performance and correlated with plasma glial fibrillary acidic protein (GFAP) level.
Conclusions: Peripheral hematological inflammatory signatures were associated with Alzheimer’s disease continuum. Higher NLR and SII levels and a composite inflammatory signature were independently associated with more advanced disease stages, cognitive impairment, and functional decline. The association between inflammatory signatures and plasma GFAP, but not amyloid or tau biomarkers, suggests a relationship between peripheral inflammatory profiles and glial-related biomarker alterations that requires further longitudinal investigation.
Related
- Inflammatory Hematological Indices in Heart Failure with Preserved Ejection Fraction: Associations with Disease Severity and 12-Month Outcomes
- Associations of Serum Cartilage Oligomeric Matrix Protein with Body Composition and Hematological Inflammatory Indices in Postmenopausal Women
- Proteomic signatures characterized by inflammatory signaling and metabolic processes have divergent associations with 30-year incidence of coronary artery disease in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort.
- Machine Learning Based on Routine Hematological Parameters and Derived Inflammatory Indices for the Diagnosis of Schizophrenia
- Diagnostic value of hematological inflammatory indices for renal involvement in adult IgA vasculitis : A cross-sectional study
BibTeX
@article{he2026peripheral,
title = {{Peripheral hematological inflammatory signatures in the amyloid-defined Alzheimer’s disease continuum: associations with disease stage, cognitive function, and astroglial activation}},
author = {Ying He and Jingyu Zhou and Xiaolei Wu and Jing Sheng and Ziyi Zhang and Zijuan Feng and Shuting Zhang},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1959479},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1959479/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Peripheral hematological inflammatory signatures in the amyloid-defined Alzheimer’s disease continuum: associations with disease stage, cognitive function, and astroglial activation
AU - Ying He
AU - Jingyu Zhou
AU - Xiaolei Wu
AU - Jing Sheng
AU - Ziyi Zhang
AU - Zijuan Feng
AU - Shuting Zhang
PY - 2026
DA - 2026/10/14
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1959479
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1959479/full
AB - Background: Peripheral immune-inflammatory dysregulation has been implicated in Alzheimer’s disease (AD) and cognitive decline. However, whether routinely available hematological inflammatory indices are associated with biological and clinical stages across the AD continuum and provide incremental information beyond established risk factors remains unclear. We aimed to investigate the associations of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and hemoglobin-to-red blood cell distribution width ratio (HRR) with AD continuum stage, cognition, and AD biomarkers. Methods: This cross-sectional study included 267 participants who underwent comprehensive cognitive assessment, peripheral blood testing, and amyloid-β positron emission tomography (Aβ-PET) imaging. Participants were categorized into three groups according to cognitive status and available amyloid biomarker profiles: cognitively unimpaired (CU-Aβ ⁻ ), amyloid-positive mild cognitive impairment (MCI-Aβ ⁺ ), and amyloid-positive Alzheimer’s disease dementia (AD-Aβ ⁺ ). Hematological inflammatory indices, including neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and hemoglobin-to-red cell distribution width ratio (HRR), were calculated from routine blood parameters. A composite inflammatory index (Inflam_PC1) was derived using principal component analysis. Ordinal logistic regression models were used to examine the associations between inflammatory indices and AD continuum stage after adjustment for demographic, vascular, metabolic, and genetic factors. Results: Inflammatory profiles differed across the AD continuum, with increased NLR and SII and decreased HRR levels in more advanced stages. Higher NLR (OR = 1.54, 95% CI: 1.25-1.91, P < 0.001) and SII (OR = 1.29 per 100-unit increase, 95% CI: 1.15-1.45, P < 0.001) were independently associated with advanced AD continuum stages, whereas HRR was not. The composite inflammatory signature showed the strongest association (OR = 1.63 per SD increase, 95% CI: 1.30-2.03, P < 0.001) and provided incremental statistical improvement beyond conventional risk factors. Higher inflammatory burden was associated with poorer cognitive and functional performance and correlated with plasma glial fibrillary acidic protein (GFAP) level. Conclusions: Peripheral hematological inflammatory signatures were associated with Alzheimer’s disease continuum. Higher NLR and SII levels and a composite inflammatory signature were independently associated with more advanced disease stages, cognitive impairment, and functional decline. The association between inflammatory signatures and plasma GFAP, but not amyloid or tau biomarkers, suggests a relationship between peripheral inflammatory profiles and glial-related biomarker alterations that requires further longitudinal investigation.
SN - 1664-3224
ER -